Neurological Sciences ( IF 3.3 ) Pub Date : 2020-07-06 , DOI: 10.1007/s10072-020-04554-8 Shu Wang 1 , Meng Zhao 1 , Tianfu Li 2, 3, 4 , Chunsheng Zhang 1 , Jian Zhou 1 , Mengyang Wang 2 , Xiongfei Wang 1 , Kaiqiang Ma 1 , Guoming Luan 1, 3, 4 , Yuguang Guan 1, 3, 4
Purpose
Temporal lobe epilepsy patients treated with hippocampal deep brain stimulation (Hip-DBS) have rarely been reported before. Preoperative and postoperative cognitive function is seldom analyzed.
Methods
Seven patients with drug-resistant temporal lobe epilepsy were included in this study. Bilateral Hip-DBS was performed in these patients. The stimulator was activated 1 month after the implantation. Then, the patients returned for further adjustments 4 months after the surgery and reprogramming every year. The seizure frequency, Wechsler Adult Intelligence Scale-IV, and Wechsler memory scale-IV were assessed blindly as the outcomes at each follow-up.
Results
After a mean 48-month follow-up, the mean seizure frequency significantly decreased (p = 0.011, paired t test; decrease of 78.1%). One patient (14.3%) was seizure-free by the last follow-up; six of seven (85.7%) patients had reductions in seizure frequency of at least 50%; one patient (14.3%) who did not comply with the antiepileptic drug instructions had a less than 50% reduction in seizure frequency. In addition, there were no significant decreases in intelligence or verbal and visual memory from baseline to the last follow-up (p = 0.736, paired t test; p = 0.380, paired t test, respectively).
Conclusion
Hip-DBS could provide acceptable long-term efficacy and safety. For patients with drug-resistant temporal lobe epilepsy who are not suitable for resective surgery, Hip-DBS could become a potential therapeutic option.
中文翻译:
耐药性颞叶癫痫患者双侧海马深部脑刺激的长期疗效和认知作用。
目的
以前很少报道过用海马深脑刺激(Hip-DBS)治疗的颞叶癫痫患者。术前和术后的认知功能很少分析。
方法
这项研究纳入了7例耐药性颞叶癫痫患者。在这些患者中进行了双侧Hip-DBS。植入后1个月激活刺激器。然后,患者在手术后四个月返回并作进一步调整,并每年重新编程。癫痫发作频率,韦氏成人智力量表IV和韦氏记忆量表IV被盲目评估为每次随访的结果。
结果
在平均48个月的随访之后,平均癫痫发作频率显着下降(p = 0.011,配对t检验;下降78.1%)。末次随访中无1例患者(14.3%)无癫痫发作。七名患者中有六名(85.7%)的癫痫发作频率降低了至少50%;一位不遵守抗癫痫药说明书的患者(14.3%)的癫痫发作频率降低了不到50%。此外,从基线到最后一次随访,智力或言语和视觉记忆没有显着下降(分别为p = 0.736,配对t检验;p = 0.380,配对t检验)。
结论
Hip-DBS可以提供可接受的长期疗效和安全性。对于不适合切除手术的耐药性颞叶癫痫患者,Hip-DBS可能成为潜在的治疗选择。